A common conclusion of numerous published reports investigating IGF/IGF1R function in mammary tumorigenesis in vivo is that dysregulation of this pathway is sufficient to either induce tumorigenesis or to modulate the primary tumor phenotype (for summary, see Table 1). The gene discussed is IGF1R; the disease is neoplasm.